These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37803318)

  • 1. CERCAM is a prognostic biomarker associated with immune infiltration of macrophage M2 polarization in head and neck squamous carcinoma.
    Yang Y; Yan C; Chen XJ
    BMC Oral Health; 2023 Oct; 23(1):724. PubMed ID: 37803318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analyses proposed xenotropic and polytropic retrovirus receptor 1 as a potential diagnostic and prognostic biomarker and immunotherapeutic target in head and neck squamous cell carcinoma.
    Wang L
    Auris Nasus Larynx; 2023 Feb; 50(1):134-150. PubMed ID: 35690506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Role and Prognostic Value of TMEM208 in Head and Neck Squamous Cell Carcinoma.
    Yang J; Song T
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):909-919. PubMed ID: 38546073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTHRC1 is a prognostic biomarker correlated with immune infiltration in head and neck squamous cell carcinoma.
    Zhang Z; Ren X; Wang Y; Liu P; Lin P; Jin S; Xu C
    BMC Oral Health; 2024 Jun; 24(1):742. PubMed ID: 38937712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma.
    Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y
    PeerJ; 2023; 11():e16237. PubMed ID: 37842043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma.
    Yang ML; Zhang JH; Li S; Zhu R; Wang L
    Pathol Oncol Res; 2021; 27():1609967. PubMed ID: 34840533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma.
    Lu T; Chen Y; Gong X; Guo Q; Lin C; Luo Q; Tu Z; Pan J; Li J
    Cancer Med; 2021 Nov; 10(21):7847-7862. PubMed ID: 34590792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of LAYN in HPV-related head and neck squamous cell carcinoma and its influence on immune cell infiltration.
    Chen Q; Chen J; Lu Z; Nian R; Li W; Yao Z; Mou S; Liu Y; Cao X; He W; Zhu C
    Discov Oncol; 2024 Mar; 15(1):57. PubMed ID: 38430385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Overexpression of Fibronectin 1 Promotes Cancer Progression and Associated with M2 Macrophages Polarization in Head and Neck Squamous Cell Carcinoma Patients.
    Zhou WH; Du WD; Li YF; Al-Aroomi MA; Yan C; Wang Y; Zhang ZY; Liu FY; Sun CF
    Int J Gen Med; 2022; 15():5027-5042. PubMed ID: 35607361
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
    Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DOCK8 Serves as a Prognostic Biomarker and Is Related to Immune Infiltration in Patients With HPV Positive Head and Neck Squamous Cell Carcinoma.
    Zhang Z; Bao Y; Zhou L; Ye Y; Fu W; Sun C
    Cancer Control; 2021; 28():10732748211011951. PubMed ID: 33910393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
    Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Shi Y; Huang J; Hu Y; Shen Y
    BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of HOXB9 based on comprehensive bioinformatics analysis for predicting prognosis of head and neck squamous cell carcinoma.
    Li J; Ran H; Zeng X; Yang D; Zeng X; Zhang P
    Medicine (Baltimore); 2023 Sep; 102(35):e35035. PubMed ID: 37657018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FAM3 Family as Prognostic Factors for Head and Neck Squamous Cell Carcinoma.
    Liao C; Wang Q; An J; Wang H; Xiao L; Long Q; Zhao H; Liu J; Guan X
    Comb Chem High Throughput Screen; 2023; 26(3):539-558. PubMed ID: 35538834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of PSMD7 as a prognostic factor correlated with immune infiltration in head and neck squamous cell carcinoma.
    Zhang S; Yu S; Wang J; Cheng Z
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33687056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EXT2: a novel prognostic and predictive biomarker for head and neck squamous cell carcinoma.
    Selvan AJA; Kannan B; Pandi C; Jayaseelan VP; Arumugam P
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Mar; 137(3):282-289. PubMed ID: 38155009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic impact of the immune signature in head and neck squamous cell carcinoma.
    Baysal H; Siozopoulou V; Zaryouh H; Hermans C; Lau HW; Lambrechts H; Fransen E; De Pauw I; Jacobs J; Peeters M; Pauwels P; Vermorken JB; Smits E; Lardon F; De Waele J; Wouters A
    Front Immunol; 2022; 13():1001161. PubMed ID: 36268020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA 5-Methylcytosine Regulator NSUN3 promotes tumor progression through regulating immune infiltration in head and neck squamous cell carcinoma.
    Jin S; Li J; Shen Y; Wu Y; Zhang Z; Ma H
    Oral Dis; 2024 Mar; 30(2):313-328. PubMed ID: 35997137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.